Recently Opened Clinical Trials for August 2014 | Cancer Currents | Norris Cotton Cancer Center
Skip to main content
Norris Cotton Cancer Center
In This Section

Recently Opened Clinical Trials for August 2014

Alexey Danilov
Assistant Professor
Molecular Therapeutics
Piramal Life Sciences, Limited
A Phase I/Ib study of P1446A-05 in patients with relapsed/refractory Chronic Lymphocytic Leukemia (CLL)

Marc Ernstoff
Immunology and Cancer Immunotherapy
Acceleron Pharma Inc
A Phase 2 randomized, double-blind study of dalantercept plus axitinib compared to placebo plus axitnib in patients with advanced renal cell carcinoma

Merck and Company
Expanded access of MK-3475 in metastatic melanoma patients with limited to no treatment options

Lionel Lewis
Molecular Therapeutics
GlaxoSmithKline Group
BRF114144: A rollover study to provide continued treatment with GSK2118436 to subjects with BRAF mutation-positive tumors

GlaxoSmithKline Group
A two-part study to evaluate the effect of repeat oral dosing of GSK2118436 on cardiac repolarization in subjects with V600 BRAF mutation-positive tumors: An open-label, dose escalating safety leading study followed by a single-sequence, placebo-controlled, single-blind study

David Roberts
Cancer Imaging and Radiobiology
Quantification of ALA-induced PpIX fluorescence during brain tumor resection